Treatment of chronic hepatitis C with interferon-free therapy
Welcome to licensed pharmacies in Poland:
Non-prescription medicines delivery across Europe.
Frequently ordered: potency boosters (sildenafil OTC), quit smoking aids.
Can Disulfiram/Esperal be used together with Epclus tablets?
Good morning I have a question. My partner wants to hide in Esperal, but from Marc he will continue to take EPCLUS tablets for the liver. Can it sew up or better not because what I know EPCLUSA can not be used with other drugs
DisulfiramEpclusaEsperalCzy można łączyć leki ze sobą?Is it safe to take several medicines at the same time?Lekarz chorób zakaźnychLiverTreatment of chronic hepatitis C with interferon-free therapy
1 answer
* required field
You can drag the photo file here.
* required field
Notify of a new answer.
Other messages will not be sent.
Other messages will not be sent.
Aleksandra Berdys Pharmacist
16 months ago
I have not found any information that the drugs Epclusa and Esperal (Disulfiram) interacted. Nevertheless, these are prescription medicines and it is he who makes the final decision. Epclusa is an antiviral medicine used to treat hepatitis C. The only contraindications to the use of Esperal inserts are: allergy (hypersensitivity) to substances of the drug, state of alcoholic intoxication, consumption of beverages containing ethyl alcohol or use of preparations containing alcohol in the last 12 hours before the procedure, confirmed heart failure, ischemic heart disease, hypertension, previous peripheral circulatory failure, mental disorders. Of course, the use of the drug is only due to the signing of the consent by the patient. More about disulfiram - the active ingredient of Esperal here: https://www.gdziepolek.pl/substancje/disulfiram
Appreciate the answerer and highlight the question on the home page
User questions and answers that provide feedback about products are not verified for the purchase or use of the product. Companies often order anonymous comments to form positive opinions about their products, or negative ones about competitors. Therefore, be guided by the information in the pharmacists' responses in the first place.